Acceptability of a first-line anti-tuberculosis formulation for children: qualitative data from the SHINE trial

SETTING: We conducted a qualitative exploration into the palatability and acceptability of a novel fixed-dose combination (FDC) anti-tuberculosis drug. This study was nested in the SHINE (Shorter treatment for minimal TB in children) trial, which compares the safety and efficacy of treating non-seve...

Descripción completa

Detalles Bibliográficos
Autores principales: Wademan, D. T., Busakwe, L., Nicholson, T. J., van der Zalm, M., Palmer, M., Workman, J., Turkova, A., Crook, A. M., Thomason, M. J., Gibb, D. M., Seeley, J., Hesseling, A., Hoddinott, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union Against Tuberculosis and Lung Disease 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6903808/
https://www.ncbi.nlm.nih.gov/pubmed/31931909
http://dx.doi.org/10.5588/ijtld.19.0115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6903808/
https://www.ncbi.nlm.nih.gov/pubmed/31931909
http://dx.doi.org/10.5588/ijtld.19.0115

Ejemplares similares